US04683R1068 - AVIR (XNAS)
ATEA PHARMACEUTICALS INC Aktie
3,82 USD
Aktuelle Kurse von ATEA PHARMACEUTICALS INC
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NASDAQ |
AVIR
|
USD
|
19.09.2024 22:00
|
3,82 USD
| 3,99 USD | -4,26 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | -1,29 % | -0,13 % | 9,14 % | -3,05 % | 17,54 % | -87,41 % |
Firmenprofil zu ATEA PHARMACEUTICALS INC Aktie
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The company also develops AT-752, an oral purine nucleoside prodrug product candidate, which has completed Phase Ia clinical trial for the treatment of dengue; AT-777, an NS5A inhibitor; AT-787, a co-formulated, oral, pan-genotypic fixed dose combination of AT-527 and AT-777 for the treatment of hepatitis C virous (HCV); and AT-281, a pharmaceutically acceptable salt for the treatment or prevention of an RNA viral infection, including dengue fever, yellow fever, Zika virus, and coronaviridae viral infection, as well as Ruzasvir, an investigational oral, pan genotypic NS5A inhibitor for the treatment of chronic HCV infection. It has a license agreement with Merck & Co, Inc. for development and commercialization of ruzasvir for the treatment of HCV. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Unternehmensdaten zur ATEA PHARMACEUTICALS INC Aktie
Name ATEA PHARMACEUTICALS INC
Firma Atea Pharmaceuticals, Inc.
Symbol AVIR
Website https://ateapharma.com
Heimatbörse
NASDAQ
ISIN US04683R1068
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. Jean-Pierre Sommadossi Ph.D.
Marktkapitalisierung 304 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,1 T
Adresse 125 Summer Street, 02110 Boston
IPO Datum 2020-10-30
Ticker Symbole
Name | Symbol |
---|---|
NASDAQ | AVIR |
Weitere Aktien
Investoren die ATEA PHARMACEUTICALS INC halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024